ABBOTINDIABSEAbbott India LtdHighNeutral
Announced Mon, 24 Nov · 13:59 IST

Approval of Central Government for appointment of Managing Director

Management Changes View source PDF

ABBOTINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Abbott India has received approval from the Central Government (Ministry of Corporate Affairs) under Section 196 of the Companies Act, 2013 for the appointment of Mr. Kartik Rajendran (DIN: 09527717) as Managing Director. The appointment is for a period of 5 years, effective from June 14, 2025 to June 13, 2030. This follows earlier intimation by the company on May 7, 2025 and August 13, 2025 about the proposed appointment. The government order was issued on November 21, 2025 and was communicated to the stock exchange on November 24, 2025.

Likely market impact

The leadership position at Abbott India is now formally confirmed with full regulatory clearance, removing any prior uncertainty around the MD appointment. For shareholders, this provides stability at the top management level for the next five years, though the appointment had likely been in effect since June 2025 already.